Alternatively, CAFs secretome may be maintained during tumor progression through enhanced stromal cell-derived factor (SDF)-1 autocrine signaling loops and increased co-expression of receptors, such as TGF-beta-RI and CXC receptor (CXCR)-4 (Kojima et al., 2010). Here, CXCL12 is linked to neoplasm.